A61P 37 - Drugs for immunological or allergic disorders

Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141)
11/2004
11/04/2004	US20040220225 Non-imidazole alkylamines as histamine H3-receptor ligands and their therapeutic applications
11/04/2004	US20040220204 mixture of fatty ester, alkylene carbonate, butylene glycol, diethylene glycol, monoalkyl ether and thickeners
11/04/2004	US20040220159 osteoporosis, periodontal diseases, aging resistance, antilipemic agents, anticholesterol agents, canticancer agents, antiarthritic agents, sexual disorders
11/04/2004	US20040220148 5-Membered ring heterocycles as inhibitors of leucocyte adhesion and as VLA-4 antagonists
11/04/2004	US20040220142 Imine-forming polysaccharide adjuvants and immunostimulants
11/04/2004	US20040220133 Composition and method for inhibiting platelet aggregation
11/04/2004	US20040220092 G-protein coupled receptors
11/04/2004	US20040219224 Spherical protein particles and methods for making and using them
11/04/2004	US20040219203 Anti-CD74 immunoconjugates and methods
11/04/2004	US20040219202 Pharmaceutical composition comprising lipids comprising a polar and a nonpolar moiety
11/04/2004	US20040219200 Topical patch preparation containing a delayed-type hypersensitivity inducer and methods for using the same
11/04/2004	US20040219199 Topical patch preparation containing a delayed-type hypersensitivity inducer and methods for using the same
11/04/2004	US20040219181 Sustained release drug delivery devices with coated drug cores
11/04/2004	US20040219160 Zwitterionic immunomodulators for the treatment of asthma and allergy
11/04/2004	US20040219157 Composition comprising a prebiotic for decreasing inflammatory process and abnormal actibation of non-specific immune parameters
11/04/2004	US20040219156 Immunotherapy of B cell malignancies and autoimmune diseases using unconjugated antibodies and conjugated antibodies and antibody combinations and fusion proteins
11/04/2004	US20040219148 comprising an agent that targets an interleukin-15 receptor and a second agent that inhibits a costimulatory signal transmitted between a T cell and an antigen-presenting cell; treating autoimmune diseases, AIDS, vascular injuries or organ, tissue or cell transplant recipients
11/04/2004	CA2714572A1 A method and compound for lowering allergy risk
11/04/2004	CA2708045A1 A pharmaceutical compound
11/04/2004	CA2528503A1 Tolerance to graft prior to thymic regeneration
11/04/2004	CA2526880A1 Cyclic quaternary amino derivatives as modulators of chemokine receptors
11/04/2004	CA2523459A1 Method of accumulating allergen-specific t cell antigen determinant in plant and plant having the antigen determinant accumulated therein
11/04/2004	CA2522362A1 Immunomodulatory product obtained from a bifidobacterium culture and compositions containing the same
11/04/2004	CA2521847A1 Use of b7-h3 as an immunoregulatory agent
11/04/2004	CA2521531A1 Pharmaceutical composition comprising edible acids or the acid salts and its use
11/04/2004	CA2520655A1 Compositions for mucosal and oral administration comprising hcg fragments
11/04/2004	CA2520097A1 Truncated baff receptors
11/03/2004	EP1473300A1 Pharmaceutical composition for the treatment of psoriasis and other skin diseases
11/03/2004	EP1473294A2 Substituted 1,3-oxathiolanes with antiviral properties
11/03/2004	EP1473041A2 Anti-allergic pharmaceutical composition
11/03/2004	EP1473038A1 Method of protecting living body from foreign factor and composition therefor
11/03/2004	EP1472544A2 Diagnostics and therapeutics for diseases associated with a new human 5-ht6 receptor
11/03/2004	EP1472379A1 Polymorphisms in the human gene for tpmt and their use in diagnostic and therapeutic applications
11/03/2004	EP1472377A2 Genetic polymorphisms in the preprotachykinin gene
11/03/2004	EP1472364A2 Truncated aggrecanase molecules
11/03/2004	EP1472341A2 Compositions and methods for restoring immune responsiveness in patients with immunological defects
11/03/2004	EP1472279A1 A method for inhibiting "melanoma inhibitory activity" mia
11/03/2004	EP1472273A2 Compositions and methods for the treatement of immune related diseases
11/03/2004	EP1472272A1 Crystalline complexes of fluticasone 2-furoate
11/03/2004	EP1472269A1 RNA INTERFERENCE MEDIATED INHIBITION OF INTERLEUKIN GENE EXPRESSION USING SHORT INTERFERING NUCLEIC ACID (siNA)
11/03/2004	EP1472267A2 Rna interference mediated inhibition of protein tyrosine phosphatase type iva (prl3) gene expression using short interfering nucleic acid (sina)
11/03/2004	EP1472257A1 Inhibitors of alpha l beta 2 integrin mediated cell adhesion
11/03/2004	EP1472256A1 Piperidine derivatives
11/03/2004	EP1472251A1 Novel fluorene carboxylic acid esters, methods for the production thereof, and use of the same as pharmaceuticals
11/03/2004	EP1472245A2 Heteroaryl compounds useful as inhibitors of gsk-3
11/03/2004	EP1472244A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
11/03/2004	EP1472243A1 Piperidine derivatives and their use as antagonists of tachykinins
11/03/2004	EP1472241A1 Cytoprotective benzofuran derivatives
11/03/2004	EP1472222A1 Piperidylcarboxamide derivatives and their use in the treatment of tachykinim-mediated diseases
11/03/2004	EP1472221A2 Substituted indoles, method for production and use thereof for the inhibition of pain
11/03/2004	EP1472209A2 Lipoxin a4 analogs
11/03/2004	EP1471970A2 NOVEL MAMMALIAN MULTIPOTENT STEM CELLS AND COMPOSITIONS, METHODS OF PREPARATION AND METHODS OF ADMINISTRATION THEREOF
11/03/2004	EP1471938A2 Human monoclonal antibodies against cd30
11/03/2004	EP1471933A1 Albumin-fused anti-angiogenesis peptides
11/03/2004	EP1471928A1 Hiv inhibiting proteins
11/03/2004	EP1471927A2 Diagnostics and therapeutics for diseases associated with neuromedin u1 receptor (nmu1)
11/03/2004	EP1471920A2 Process for preparing water-soluble phosphonooxymethyl derivatives of alcohol and phenol
11/03/2004	EP1471919A1 Pharmaceutical compositions comprising 17alpha-furanylesters of 17beta-carbothioate androstanes with a muscarinic receptor antagonist
11/03/2004	EP1471918A2 Use of modified pyrimidine compounds to promote stem cell migration and proliferation
11/03/2004	EP1471915A2 2,4-pyrimidinediamine compounds and their uses
11/03/2004	EP1471907A2 Use of tyrosine kinase inhibitors for treating autoimmune diseases
11/03/2004	EP1471901A1 Spermidine derivatives for the treatment of chronic neurodegenerative diseases
11/03/2004	EP1471896A1 Formulations for inhalation
11/03/2004	EP1471895A1 Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist
11/03/2004	EP1471884A1 Pharmaceutical formulation comprising an androstane derivative and a solubilising agent in an aqueous liquid carrier
11/03/2004	EP1471870A2 Use of lipid conjugates in the treatment of disease
11/03/2004	EP1435906A4 Method for producing biologically active products
11/03/2004	EP1404315B1 Synergistic compositions of n-acylhomoserine lactones and 4-quinolones
11/03/2004	EP1347974B1 Aminotriazolopyridiine derivatives as adenosine receptor ligands
11/03/2004	EP1250331B1 Formulation for protection against oxidative stress containing benzofuranone derivatives
11/03/2004	EP1235814B1 3,4-DIHYDRO-(1H)QUINAZOLIN-2-ONE COMPOUNDS AS CSBP/p38 KINASE INHIBITORS
11/03/2004	EP1189883B1 Substituted pyrrolidines as cell adhesion inhibitors
11/03/2004	EP1169338B1 Low-molecular inhibitors of complement proteases
11/03/2004	EP1105371B1 Novel aryl sulphonamide amino acid esters and analogues
11/03/2004	EP0956021B1 L-beta-dioxolane uridine analogs for treating and preventing infections by ebv, vzv and hv-8
11/03/2004	EP0788305B1 Composition for inactivating irritants in fluids
11/03/2004	EP0722324B1 Pharmaceutical composition for immunoenhancement therapy
11/03/2004	CN1543692A Apparatus for a quick release safety connector assembly
11/03/2004	CN1543502A CD8 alpha + lymphoid dendritic cell differentiated from human hematopoietic stem cell and a method for differentiation
11/03/2004	CN1543501A Method of extended culture for antigen-specific cytotoxic t lymphocytes
11/03/2004	CN1543362A Medical products comprising a haemocompatible coating, production and use thereof
11/03/2004	CN1543352A Method and material for treating immune diseases
11/03/2004	CN1543347A Use of BIBN4096 in combination with other antimigraine drugs for the treatment of migraine
11/03/2004	CN1543345A Methods for selective immunomodulation using pimecrolimus
11/03/2004	CN1543338A Chitin microparticles and their medical uses
11/03/2004	CN1542019A Anti human non-Hodgkin's lymphoma chimeric antibody and its derivative and application
11/03/2004	CN1542010A Azolo triazines and pyrimidines
11/03/2004	CN1542006A Salt of phenylacetyl-(N-methyl)leucine-aspartic acid- phenylalanine-(N-methyl)piperazine
11/03/2004	CN1542001A Small molecule inhibitors of rotamase enzyme activity
11/03/2004	CN1541713A Cross-breed vaccine carrier and its application
11/03/2004	CN1541711A Regulation of immune responses by manipulation of intermediary metabolite levels
11/03/2004	CN1541707A Medicinal composition for treating serious acute respiratory syndrome
11/03/2004	CN1541706A Inhibitor and stimulator of stem cell proliferation and uses thereof
11/03/2004	CN1541664A Antisenescing and immunoregulating Chinese and Western medicinal mixture
11/03/2004	CN1541643A Use of Wangzaozi secondary element as immunological inhibitors
11/03/2004	CN1173996C Atractylodes polyose with antineoplastic and immunoregualting functions and its preparing process and application
11/03/2004	CN1173974C Piperidylaminomethyltrifluoromethyl cyclic ether compound as p substance antagonist
11/03/2004	CN1173969C Novel lipoic acid derivatives, their preparation method and medical use, and pharmaceutical compositions containing them
11/03/2004	CN1173909C 20 kinds of modified vitamin D series derivatives, preparing and drug thereof
11/03/2004	CN1173735C Use of anti-gp 39 antibodies for treatment and/or reversal of lupus and associated kidney disease

1 ... 593 594 595 596 597 598 599 600 601 602 603 604 605 606 607 608 609 610 611 612 613 ... 1172